Insilico Medicine
What They Do edit
AI-driven drug discovery company using deep learning for target identification, molecule generation, and clinical trial optimization. One of the most established AI pharma companies globally.
Activity (April 2026) edit
Hosted "Pharma AI Spring Kickoff 2026" webinar on AI drug discovery applications.[1] CEO discussed practical AI applications in pharma R&D, emphasizing real results over hype.[2]
Funding edit
Valuation: Est. $1B+ (AI drug discovery leader)